# The Effects of Hemodialysis on Serum Sclerostin Levels

> **NCT03952819** · — · COMPLETED · sponsor: **Abant Izzet Baysal University** · enrollment: 56 (actual)

## Conditions studied

- Diabetes Mellitus
- Renal Failure
- Hemodialysis Access Failure

## Interventions

- **DIAGNOSTIC_TEST:** serum sclerostin

## Key facts

- **NCT ID:** NCT03952819
- **Lead sponsor:** Abant Izzet Baysal University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-14
- **Primary completion:** 2018-11-15
- **Final completion:** 2018-12-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03952819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03952819, "The Effects of Hemodialysis on Serum Sclerostin Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03952819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*